I’m booked to take a massive dose of psilocybin in mid-July as part of yet another drug trial. I’ve spent weeks being screened, involving blood work, physical exams, endless questionnaires, and ...
Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo Nordisk is testing the GLP-1 in smaller doses in the late-stage OASIS 5 study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results